医院前抗生素治疗的影响因败血栓冲击的来源而异
Romain Jouffroy1,2,3,4,5,6, Vincent Garrouste7, Basile Gilbert8
1LI2RSO, Orléans University Hospital Orléans University, 45100, Orleans, France. romain.jouffroy@gmail.com.
Journal of intensive care
|March 2, 2026
概括
对于败血性休克患者的医院前抗生素显著降低了30天死亡率. 移动重症监护室 (MICU) 早期给予抗生素对于改善严重败血症病例的结果至关重要.
科学领域:
- 紧急医疗 紧急医疗
- 临界护理医学 临界护理医学
- 传染性疾病 传染性疾病
背景情况:
- 国际指导方针提倡使用早期败血症管理包来降低死亡率.
- 早期服用抗生素至关重要,特别是对于需要立即干预的败血症休克患者.
- 这项研究调查了医院前抗生素对移动重症监护室 (MICU) 治疗的败血症休克患者30天死亡率的影响.
研究的目的:
- 评估医院前抗生素给药与败血症休克患者30天死亡率之间的关联.
- 为了比较在入院前接受抗生素治疗的患者与未接受抗生素治疗的患者的结果.
- 分析医院前抗生素的效果,基于所谓的感染性休克的起源.
主要方法:
- 法国全国观测队列研究 (2016年5月至2021年12月).
- 模拟后期随机对照试验,使用加权的Cox比例危险模型.
- 二次分析使用加权后勤回归来评估根据败血栓冲击来源的结果.
主要成果:
- 医院前使用抗生素与30天死亡风险降低有关 (RR=0.64,95% CI [0.41-0.97]).
- 在肺部和尿路起源的败血症休克中观察到显著的死亡率降低.
- 该研究包括530名患者,30天死亡率为31%.
结论:
- 在MICU管理的败血症休克患者中,医院前的抗生素给药与30天死亡率的降低有关.
- 医院前抗生素的有效性取决于败血症休克的起源.
- 需要进一步的前性研究来证实这些发现,并探索医院前护理包的全部好处.
相关概念视频
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
234
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
234
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
539
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
539
01:27Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
01:26Urine Studies II: Urine Culture and Sensitivity Test
1.6K
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
1.6K
01:28Pneumonia IV: Management
963
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
963
00:57Antibiotic Selection
61.6K
Overview
61.6K